Advertisement

Topics

Advent In Talks To Buy Sanofi's European Generics Unit Zentiva For EUR 1.9 Bln

03:07 EDT 17 Apr 2018 | FinanzNachrichten

PARIS (dpa-AFX) - Advent International entered into exclusive negotiations to acquire Zentiva, Sanofi's (SNYNF, SNY) European generics business, for 1.9 billion euros. Advent's offer is firm, bind...

Original Article: Advent In Talks To Buy Sanofi's European Generics Unit Zentiva For EUR 1.9 Bln

NEXT ARTICLE

More From BioPortfolio on "Advent In Talks To Buy Sanofi's European Generics Unit Zentiva For EUR 1.9 Bln"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...